MODERATE Active Ingredient NOAEL Data Dermal Penetration

Homosalate

Also known as: 3,3,5-Trimethylcyclohexylsalicylate (Homosalate), Benzoic acid, 2-hydroxy-, 3,3,5-trimethylcyclohexyl ester, Caswell No. 482B, Coppertone, EINECS 204-260-8 (+9 more)

INCI: HOMOSALATE

Homosalate (CAS 118-56-9) is a cosmetic active ingredient functioning as Oil-soluble UVB UV filter; peak absorption ~306 nm; used as SPF booster in. NOAEL 10 mg/kg bw/day (PDF-verified against ToxValDB ECHA IUCLID); EU Regulation 1223/2009 status: restricted, max 7.34%. Industrial safety data is also available in the chemical safety database. Same-CAS public records also appear in industrial chemical safety and pharmaceutical data.

View industrial chemical safety profile for CAS 118-56-9 →

Function
Oil-soluble UVB UV filter; peak absorption ~306 nm; used as SPF booster in combination formulations; UVB-only spectrum with no UVA coverage
Editorial assessment
MODERATE
Preliminary editorial note — not a computed safety verdict.

Chemistry & Identifiers

EC Number
204-260-8

Regulatory Status

EU EU Status restricted
EU Max Conc. 7.34%
US US Status restricted
US Notes Historically marketed in the US; FDA states existing data is not sufficient to determine GRASE. Regulatory limbo alongside seven other chemical filters. Final determination pending additional safety data. Previously permitted up to 15% in the US monograph.

For full compliance data across multiple jurisdictions, use the Substance Compliance tool.

Safety Data

Margin of Safety, dermal absorption, and sensitization profile summaries for Homosalate.

Calculate MoS for your specific formulation with the MoS Calculator.

Toxicological Studies

10 study endpoints found for Homosalate. NOAEL (No Observed Adverse Effect Level) values are used to calculate the Margin of Safety per SCCS methodology.

Endpoint Value Route Species Study Type Source
NOAEL =10 mg/kg bw/day oral - repeated dose toxicity SCCS Opinion
NOAEL =10 mg/kg bw/d oral rat dermal absorption SCCS Opinion
NOAEL =10 mg/kg bw/day oral - repeated dose toxicity SCCS Opinion
NOAEL =10 mg/kg bw/day oral - repeated dose toxicity SCCS Opinion
NOAEL =10 mg/kg bw/d oral rat dermal absorption SCCS Opinion
NOAEL =10 mg/kg bw/day oral - repeated dose toxicity SCCS Opinion
NOAEL =10 mg/kg bw/day oral - repeated dose toxicity SCCS Opinion
NOAEL =10 mg/kg bw/d oral rat dermal absorption SCCS Opinion
NOAEL =10 mg/kg bw/day oral - repeated dose toxicity SCCS Opinion
NOAEL =10 mg/kg bw/day oral - repeated dose toxicity SCCS Opinion

Pre-Calculated Safety Assessment

Conditional — safe only within SCCS limits: not 10%; safe up to 7.34% in face cream and pump-spray face products

Pre-calculated NOAEL → SED → MoS audit trail for Homosalate across SCCS product categories, with measured dermal absorption where available.

SCCS NOAEL Values

NOAEL/LOAEL values cited in official SCCS opinions for Homosalate.

NOAEL LOAEL Route Species Study DA% (SCCS) Opinion
300 mg/kg/day 750 mg/kg/day Oral Rat (Wistar RccHan) Combined repeated dose + reproductive screening (OECD 422) (28 days) 100 SCCS/1622/20 (2021)
10 mg/kg/day 60 mg/kg/day Oral Rat (Wistar) Combined repeated dose + reproductive screening (OECD 422) (28 days) 100 SCCS/1638/21 (2021)

Dermal Penetration Profile

Skin absorption and penetration characteristics of Homosalate, relevant to systemic exposure and MoS calculations.

Absorption %
8-14%
Penetration Level
stratum-corneum
Penetration Depth
stratum corneum/epidermis
Molecular Weight
262.3 Da
Log P
6.2
Systemic Absorption
yes
Topical Bioavailability
5-12%
Safety Margin Factor
high
Vehicle Dependent
Yes — absorption varies by formulation

Source: SCCS Opinion

EPA ToxValDB — Toxicity Values

10 toxicity values from EPA ToxValDB (aggregated from CCTE, HPV, ToxRefDB, IRIS, and other regulatory dossiers).

Endpoint Value Species Route Duration Source
LEL =750 mg/kg-day Rat oral subchronic (developmental) EPA TSCA 8e
LOAEL =750 mg/kg-day Rat oral subchronic (developmental) EPA TSCA 8e
LOAEL =750 mg/kg-day Rat oral subchronic (developmental) EPA TSCA 8e
LOAEL =750 mg/kg-day Rat oral subchronic (developmental) EPA TSCA 8e
LOAEL =300 mg/kg-day Rat oral subchronic (developmental) EPA TSCA 8e
LOAEL =300 mg/kg-day Rat oral subchronic (developmental) EPA TSCA 8e
LOAEL =300 mg/kg-day Rat oral subchronic (developmental) EPA TSCA 8e
LOAEL =750 mg/kg-day Rat oral subchronic (developmental) EPA TSCA 8e
LOAEL =750 mg/kg-day Rat oral subchronic (developmental) EPA TSCA 8e
LOAEL =300 mg/kg-day Rat oral subchronic (developmental) EPA TSCA 8e

HRIPT Human Patch Test Studies

2 human repeat insult patch tests aggregated from dermatological literature.

Test Type N Sensitized Dose µg/cm² NESIL µg/cm² Potency
HRIPT - 0 - - non-sensitizer
HMT - 0 - - -

Endocrine Disruptor Evidence (Expanded)

Cross-referenced EDC classifications, mechanism data, and dose-response evidence from EDLists, SIN List, and cosmetic-specific detail sources.

Under investigation Evidence: Moderate (2021)
Health effects: Yes
Affected pathways: Estrogenic, Anti-androgenic
Regulatory framework: Cosmetics

Source list: II (former)

Cosmetic-Specific Mechanism
Category: UV filter
Receptor targets: ERα, AR
LOEC: 1.56 µM
EU status: restricted (max 0.5%; SCCS concluded not safe at 10%)

agonist (ERα); antagonist (AR)

Dose-Response Data Points
Endpoint Target Value Direction
IC50_AR AR 5.87 µM antagonist
Cell proliferation ER EC50/IC50: ~3 uM (EC50, weaker than 4-MBC); LOEC: 1 uM; NOEC: 0.3 uM mixed agonist
Estrogen response element reporter activation ERa EC50/IC50: AC50 14.20 uM; LOEC: ~8.86 uM (ACC); NOEC: ~1 uM mixed agonist
AR/PR-mediated transcription (antagonist) AR; PR EC50/IC50: IC50 ~3-10 uM (AR); IC50 ~1-3 uM (PR); LOEC: 1 uM; NOEC: 0.1 uM mixed antagonist

ECHA REACH Registration

European Chemicals Agency REACH dossier and Substances of Very High Concern listing.

Registration Type
Full
Tonnage Band
1,000 - 10,000 tonnes
Substance Type
SUBSTANCE
SVHC Candidate
No

EU CosIng Annex Listing

European Commission CosIng database Annex references per Regulation (EC) No 1223/2009.

Annex VI — Permitted UV Filters
Product type: Face products with the exception of propellent spray products
Max: 7,34 %

Expanded Jurisdictional Detail

Additional regulatory detail beyond the 7-jurisdiction summary: Saudi SFDA, Korea MFDS, ASEAN ACD, Japan/Korea, Brazil/India, and cross-jurisdictional restriction entries.

KR Korea MFDS Annex 2 (Restricted)
Category: UV Filter. Max: 10%.
SA Saudi SFDA (VI - UV Filters)
Max: 0.1.
JPKR Japan/Korea Cosmetics
Japan (Positive (UV Absorber)): max 10.0
Japan (Restricted): max 10%
Korea (Restricted): max 10%
BRIN Brazil/India Cosmetics
India: Permitted UV Filter · max 0.1
Additional Jurisdictional Restrictions (9)
Jurisdiction Status Max % Product Type
JP restricted 10% All cosmetics
CN permitted_uv_filter 10 All cosmetics
IN permitted_uv_filter 10.0 sunscreen and other cosmetic products
AU restricted - sunscreens (therapeutic)
GCC restricted 7.34 Sunscreen products
BR permitted_uv_filter 15 Sunscreen products; EU max 10%
UK restricted - -
ID permitted_uv_filter 10% (ASEAN-wide); Indonesia reducing per PerBPOM 25/2025 -

Expanded Dermal Absorption Data

Cross-database dermal penetration: EPA Dryad physics-based, Roberts Mendeley permeation, and SCCS-aggregated measured values.

Aggregated DA Values (2 records across 5 sources)
Type DA % Method Skin Model SCCS Ref
measured_in_vitro 5.3 In vitro — flow-through diffusion cells - SCCS/1622/20; SCCS/1260/22 (2020)
measured_in_vitro 11.0 - - SCCS/1564/15

Function Categories & List Membership

Cosmetic/Chemical Function Categories
Fragrance Softener and conditioner UV stabilizer
Regulatory List Membership (3)
EU Regulated in Personal Care IFRA Fragrance Transparency List EU CosIng Cosmetics Ingredient Database

Editorial summary

Preliminary editorial summary for Homosalate — not a computed safety verdict. See the sourced toxicological data above.

Regulatory Flags

uv-filter uvb oil-soluble fda-limbo systemic-absorption endocrine-disruption-concern eu-restricted eu-face-only spf-booster regulatory-downgrade-2025 product-withdrawal-july-2025 ifra_fragrance eu_cosing_listed

NOAEL Studies Summary

View details ->

Public NOAEL study rows linked to Homosalate by CAS number or substance name.

Studies
36
Lowest NOAEL
10
Highest NOAEL
100

Units vary across source rows: mg/kg bw/day, mg/kg bw/d, mg/kg/day

SCCS Opinion

Dermal Absorption

View details ->
Absorption % Method Vehicle
5.3 In vitro — flow-through diffusion cells Standard sunscreen formulation (o/w)
11.0 - -

Known Synonyms

3,3,5-Trimethylcyclohexylsalicylate (Homosalate) Benzoic acid, 2-hydroxy-, 3,3,5-trimethylcyclohexyl ester Caswell No. 482B Coppertone EINECS 204-260-8 EPA Pesticide Chemical Code 076603 Filtersol ''A'' Heliopan m-Homomenthyl salicylate NSC 164918 Salicylic acid, m-homomenthyl ester Homosalato Homosalatum UNII-V06SV4M95S

Chemical Function

UV stabilizer Softener and conditioner Fragrance

Regulatory Lists

Europe; Personal care Canada; consumer_product; Substances in Products - Canada (4/2014) inert_ingredient; non_food_use; Pesticides IFRA Transparency pharmaceutical Canada; pharmaceutical Canada; pharmaceutical

Australian Status

AICIS status: listed

Cross-Vertical Safety Context

Same-CAS public records found in pharmaceutical data.

SOURCE ChEMBL / DrugCentral / FAERS DB_PHARMA CAS match

Pharmaceutical Data

Same-CAS rows from the pharmaceutical spoke database.

Compound
HOMOSALATE
ChEMBL ID
CHEMBL1377575
Max Phase
2
Adverse Event Associations
95
View full pharmaceutical profile →

Frequently Asked Questions

Is Homosalate safe in cosmetics?

Homosalate has a safety rating of "MODERATE" in our database. EU status: restricted. US status: restricted. 10 toxicological study endpoint(s) are available in our database.

Is Homosalate allowed in the EU?

Homosalate EU regulatory status: restricted. Maximum allowed concentration: 7.34%. This is based on EU Regulation 1223/2009 and its amendments.

What does Homosalate do in cosmetics?

Homosalate functions as: Oil-soluble UVB UV filter; peak absorption ~306 nm; used as SPF booster in combination formulations; UVB-only spectrum with no UVA coverage. It is classified as a Active Ingredient in our database. CAS number: 118-56-9.

What is the NOAEL for Homosalate?

The NOAEL (No Observed Adverse Effect Level) for Homosalate is =10 mg/kg bw/day based on a repeated dose toxicity study via oral route in rat. A total of 10 study endpoints are available. Source: SCCS Opinion.

Is Homosalate used outside cosmetics?

Homosalate also appears in industrial chemical safety and pharmaceutical data. The cross-vertical cards on this page render same-CAS public rows from the matched databases.

Does Homosalate have different safety status in cosmetics vs industrial chemicals?

Homosalate is classified GHS CMR hazard (H315, H319, H335, H361d, H410) in the chemicals database but is restricted in EU cosmetics at max 7.34%.

Is Homosalate in Your Products?

Scan any product label with Piro — our free ingredient scanner. Point your camera at the ingredients list and get instant safety scores for every ingredient.

Try Piro Free →

Analyze Your Full Ingredient List

Paste any INCI list into the Decoder for instant safety analysis, or calculate the Margin of Safety for Homosalate in your formulation.